PPT-ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,

Niraparib and Temozolomide in Patients with Previously Treated incurable Ewing Sarcoma CoPrincipal Investigators Sandra Strauss MD PhD University College London

parp tmz patients niraparib tmz parp niraparib patients sarcoma esp1 treated ewing temozolomide response agents sarc025 inhibitor combination tumor

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/744151" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "ESP1/SARC025 Global Collaboration: A Pha..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.